Filing Details

Accession Number:
0001562180-20-007070
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-03 18:05:43
Reporting Period:
2020-12-01
Accepted Time:
2020-12-03 18:05:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX Pharmaceutical Preparations (2834) 320162505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507220 A Michael Metzger C/o Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-01 15,000 $7.20 32,659 No 4 M Direct
Common Stock Disposition 2020-12-01 15,000 $22.97 17,659 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-12-01 15,000 $0.00 15,000 $7.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-06-01 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 705,824 options to purchase shares of common stock that are vested and immediately exercisable and a total of 565,416 options to purchase shares of common stock that have not yet vested.
  2. This option is fully vested.